What Factors are Important to Patients when Assessing Treatment Response: An International Cross-sectional Survey
DOI:
https://doi.org/10.2340/00015555-2480Keywords:
eczema, dermatitis, atopic, outcome assessmentAbstract
This study investigated the perspective of international patients on individual symptoms of atopic dermatitis (eczema) in determining treatment response. A questionnaire was developed to evaluate the importance of symptoms from the patient?s perspective. Patients were asked: ?How important are these features in deciding whether or not a treatment is working??, and rated symptoms on a 5-point Likert scale. Patients were approached via Harmonising Outcome Measures for Eczema (HOME) collaborators and self-selected to take part in the on-line survey. Patients from 34 countries (n=1,111) completed the survey; of these, 423 (38.3%) were parents of children with eczema. Nine items were rated as being ?quite important? or ?very important? by more than 80% of the respondents: itch, pain/soreness, skin feels hot or inflamed, bleeding, involvement of visible or sensitive body sites, cracks, sleep difficulties, amount of body affected, and weeping/oozing. These results may be of use in determining the face validity of scales from a cross-cultural patients? perspectiveDownloads
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Laura B. von Kobyletzki, Kim S. Thomas, Jochen Schmitt, Joanne R. Chalmers, Stefanie Deckert, Valeria Aoki, Elke Weisshaar, Jumoke Ahubelem Ojo, Åke Svensson
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.